Demographic data associated with patients included in the sample
Variable . | Minimal COVID-19 (n = 21) . | Severe COVID-19 (n = 11) . | MIS-C (n = 18) . |
---|---|---|---|
Age, median (IQR), y | 13 (5-17) | 15 (14-17) | 9 (7-13) |
Sex, n (%) | |||
Female | 9 (43) | 6 (55) | 9 (50) |
Male | 12 (57) | 5 (45) | 9 (50) |
Race, n (%) | |||
White | 8 (38) | 5 (45) | 8 (44) |
Black | 10 (48) | 3 (27) | 7 (39) |
Other | 3 (14) | 2 (18) | 2 (11) |
Declined or not reported | 0 | 1 (9) | 1 (6) |
Ethnicity, n (%) | |||
Hispanic | 4 (19) | 3 (27) | 3 (17) |
Not Hispanic | 17 (81) | 7 (64) | 14 (78) |
Declined | 0 | 1 (9) | 1 (6) |
BMI percentile, median (IQR) | 65 (19.9-90.23); n = 19 | 82 (65-95) | 93 (80-98) |
Pediatric intensive care unit admission, n (%) | |||
Yes | 2 (10) | 11 (100) | 13 (72) |
No | 19 (90) | 0 | 5 (28) |
Extracorporeal membrane oxygenation, n (%) | |||
Yes | 0 | 2 (18) | 0 |
No | 21 (100) | 9 (82) | 18 |
Inotropic support, n (%) | |||
Yes | 0 | 8 (73) | 12 (67) |
No | 21 (100) | 3 (27) | 6 (33) |
Invasive mechanical ventilation, n (%) | |||
Yes | 1 (5)* | 9 (82) | 4 (22) |
No | 20 (95) | 2 (18) | 14 (78) |
Liver dysfunction,†n (%) | |||
Yes | 5 (24) | 5 (45) | 3 (17) |
No | 16 (76) | 6 (55) | 15 (83) |
Renal dysfunction,‡n (%) | |||
Yes | 2 (10) | 4 (36) | 5 (28) |
No | 16 (76) | 7 (64) | 13 (72) |
Not available | 3 (14) | ||
Dialysis, n (%) | |||
Yes | 0 | 1 (9) | 0 |
No | 21 (100) | 10 (91) | 18 (100) |
Hypertension,§n (%) | |||
Yes | 11 (52) | 9 (82) | 10 (56) |
No | 10 (48) | 2 (18) | 8 (44) |
Proteinuria, n (%) | |||
Yes | 7 (33) | 8 (72) | 12 (66) |
No | 7 (33) | 3 (27) | 4 (22) |
Not available | 7 (33) | 0 | 4 (22) |
Outcome, n (%) | |||
Discharged | 21 (100) | 7 (64) | 18 (100) |
Remains hospitalized | 0 | 2 (18) | 0 |
Death | 0 | 2 (18) | 0 |
Variable . | Minimal COVID-19 (n = 21) . | Severe COVID-19 (n = 11) . | MIS-C (n = 18) . |
---|---|---|---|
Age, median (IQR), y | 13 (5-17) | 15 (14-17) | 9 (7-13) |
Sex, n (%) | |||
Female | 9 (43) | 6 (55) | 9 (50) |
Male | 12 (57) | 5 (45) | 9 (50) |
Race, n (%) | |||
White | 8 (38) | 5 (45) | 8 (44) |
Black | 10 (48) | 3 (27) | 7 (39) |
Other | 3 (14) | 2 (18) | 2 (11) |
Declined or not reported | 0 | 1 (9) | 1 (6) |
Ethnicity, n (%) | |||
Hispanic | 4 (19) | 3 (27) | 3 (17) |
Not Hispanic | 17 (81) | 7 (64) | 14 (78) |
Declined | 0 | 1 (9) | 1 (6) |
BMI percentile, median (IQR) | 65 (19.9-90.23); n = 19 | 82 (65-95) | 93 (80-98) |
Pediatric intensive care unit admission, n (%) | |||
Yes | 2 (10) | 11 (100) | 13 (72) |
No | 19 (90) | 0 | 5 (28) |
Extracorporeal membrane oxygenation, n (%) | |||
Yes | 0 | 2 (18) | 0 |
No | 21 (100) | 9 (82) | 18 |
Inotropic support, n (%) | |||
Yes | 0 | 8 (73) | 12 (67) |
No | 21 (100) | 3 (27) | 6 (33) |
Invasive mechanical ventilation, n (%) | |||
Yes | 1 (5)* | 9 (82) | 4 (22) |
No | 20 (95) | 2 (18) | 14 (78) |
Liver dysfunction,†n (%) | |||
Yes | 5 (24) | 5 (45) | 3 (17) |
No | 16 (76) | 6 (55) | 15 (83) |
Renal dysfunction,‡n (%) | |||
Yes | 2 (10) | 4 (36) | 5 (28) |
No | 16 (76) | 7 (64) | 13 (72) |
Not available | 3 (14) | ||
Dialysis, n (%) | |||
Yes | 0 | 1 (9) | 0 |
No | 21 (100) | 10 (91) | 18 (100) |
Hypertension,§n (%) | |||
Yes | 11 (52) | 9 (82) | 10 (56) |
No | 10 (48) | 2 (18) | 8 (44) |
Proteinuria, n (%) | |||
Yes | 7 (33) | 8 (72) | 12 (66) |
No | 7 (33) | 3 (27) | 4 (22) |
Not available | 7 (33) | 0 | 4 (22) |
Outcome, n (%) | |||
Discharged | 21 (100) | 7 (64) | 18 (100) |
Remains hospitalized | 0 | 2 (18) | 0 |
Death | 0 | 2 (18) | 0 |
One patient with minimal COVID-19 symptoms was admitted during a trauma team activation and was intubated for airway protection.
Defined as bilirubin levels >2 times the upper limit of normal for age, alanine aminotransferase or aspartate aminotransferase levels >3 times the upper limit of normal.
Defined according to KDIGO criteria.
Defined as blood pressure >99th percentile for age, height, and sex.